首页> 外文期刊>Journal of Clinical Epidemiology >Nonrandomized studies are not always found even when selection criteria for health systems intervention reviews include them: A methodological study
【24h】

Nonrandomized studies are not always found even when selection criteria for health systems intervention reviews include them: A methodological study

机译:即使针对卫生系统干预措施审查的选择标准包括以下内容,也不会总是找到非随机研究:方法学研究

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: Systematic reviews within the Cochrane Effective Practice and Organisation of Care Group (EPOC) can include both randomized and nonrandomized study designs. We explored how many EPOC reviews consider and identify nonrandomized studies, and whether the proportion of nonrandomized studies identified is linked to the review topic. Study Design and Setting: We recorded the study designs considered in 65 EPOC reviews. For reviews that considered nonrandomized studies, we calculated the proportion of identified studies that were nonrandomized and explored whether there were differences in the proportion of nonrandomized studies according to the review topic. Results: Fifty-one (78.5%) reviews considered nonrandomized studies. Forty-six of these reviews found nonrandomized studies, but the proportion varied a great deal (median, 33%; interquartile range, 25-50%). Reviews of health care delivery interventions had lower proportions of nonrandomized studies than those of financial and governance interventions. Conclusion: Most EPOC reviews consider nonrandomized studies, but the degree to which they find them varies. As nonrandomized studies are believed to be at higher risk of bias and their inclusion entails a considerable effort, review authors should consider whether the benefits justify the inclusion of these designs. Research should explore whether it is more useful to consider nonrandomized studies in reviews of some intervention types than others.
机译:目的:Cochrane有效实践和护理组织组织(EPOC)内的系统评价可以包括随机和非随机研究设计。我们探讨了多少EPOC审查考虑并确定了非随机研究,以及确定的非随机研究的比例是否与审查主题相关。研究设计和设置:我们记录了65篇EPOC评论中考虑的研究设计。对于考虑了非随机研究的评论,我们计算了已识别研究中非随机研究的比例,并根据评论主题探讨了非随机研究的比例是否存在差异。结果:五十一项(78.5%)评论被认为是非随机研究。这些评论中有46个发现了非随机研究,但比例差异很大(中位数为33%;四分位间距为25-50%)。与财务和治理干预措施相比,对医疗保健干预措施的审查中非随机研究的比例更低。结论:大多数EPOC审查都考虑非随机研究,但是他们发现它们的程度各不相同。由于非随机研究被认为存在较高的偏见风险,将其纳入需要付出相当大的努力,因此评价作者应考虑其益处是否足以证明将这些设计包括在内。研究应探讨在某些干预类型的评论中考虑非随机研究是否比其他类型更有用。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号